These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 33275155)

  • 1. Donor Characteristics and Regional Differences in the Utilization of HCV-Positive Donors in Liver Transplantation.
    Da BL; Ezaz G; Kushner T; Crismale J; Kakked G; Gurakar A; Dieterich D; Schiano TD; Saberi B
    JAMA Netw Open; 2020 Dec; 3(12):e2027551. PubMed ID: 33275155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Hepatitis C Virus Antibody-Positive Donor Livers in Hepatitis C Nonviremic Liver Transplant Recipients.
    Luckett K; Kaiser TE; Bari K; Safdar K; Schoech MR; Apewokin S; Diwan TS; Cuffy MC; Anwar N; Shah SA
    J Am Coll Surg; 2019 Apr; 228(4):560-567. PubMed ID: 30586641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of HCV Ab+/NAT- donors in HCV naïve renal transplant recipients to expand the kidney donor pool.
    Dao A; Cuffy M; Kaiser TE; Loethen A; Cafardi J; Luckett K; Rike AH; Cardi M; Alloway RR; Govil A; Diwan T; Sherman KE; Shah SA; Woodle ES
    Clin Transplant; 2019 Jul; 33(7):e13598. PubMed ID: 31104346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal Changes and Regional Variation in Acceptance of Hepatitis C Virus-Viremic Livers.
    Mazur RD; Goldberg DS
    Liver Transpl; 2019 Dec; 25(12):1800-1810. PubMed ID: 31539195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Varying Utilization Rates but Superior Outcomes in Liver Transplantation From Hepatitis C-positive Donors in the United States: An Analysis of the OPTN/UNOS Database.
    Bekki Y; Crismale JF; Myers B; Schiano TD; Florman S
    Transplantation; 2022 Sep; 106(9):1787-1798. PubMed ID: 35507448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early experience with the use of hepatitis C antibody-positive, nucleic acid testing-negative donors in lung transplantation.
    Watson J; Mulvihill MS; Cox ML; Rich L; Wolfe CR; Gray A; Hartwig MG
    Clin Transplant; 2019 Mar; 33(3):e13476. PubMed ID: 30609162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing Utilization and Excellent Initial Outcomes Following Liver Transplant of Hepatitis C Virus (HCV)-Viremic Donors Into HCV-Negative Recipients: Outcomes Following Liver Transplant of HCV-Viremic Donors.
    Cotter TG; Paul S; Sandıkçı B; Couri T; Bodzin AS; Little EC; Sundaram V; Charlton M
    Hepatology; 2019 Jun; 69(6):2381-2395. PubMed ID: 30706517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DCD Hepatitis C Virus-positive Donor Livers Can Achieve Favorable Outcomes With Liver Transplantation and Are Underutilized.
    Myers B; Bekki Y; Kozato A; Crismale JF; Schiano TD; Florman S
    Transplantation; 2023 Mar; 107(3):670-679. PubMed ID: 36398318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organ utilization from increased infectious risk donors: An observational study.
    L'Huillier AG; Humar A; Payne C; Kumar D
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28981193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization of Organs From Donors According to Hepatitis C Antibody and Nucleic Acid Testing Status: Time for Change.
    Kling CE; Perkins JD; Landis CS; Limaye AP; Sibulesky L
    Am J Transplant; 2017 Nov; 17(11):2863-2868. PubMed ID: 28688205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Center-level trends in utilization of HCV-exposed donors for HCV-uninfected kidney and liver transplant recipients in the United States.
    Bowring MG; Shaffer AA; Massie AB; Cameron A; Desai N; Sulkowski M; Garonzik-Wang J; Segev DL
    Am J Transplant; 2019 Aug; 19(8):2329-2341. PubMed ID: 30861279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung Transplantation from hepatitis C+ donor lungs: Reassuring midterm outcomes.
    Kim ST; Xia Y; Ho JK; Lowery E; McCarthy DP; Ardehali A
    J Heart Lung Transplant; 2024 Feb; 43(2):337-345. PubMed ID: 37866469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing Trends in Transplantation of HCV-Positive Livers Into Uninfected Recipients.
    Cholankeril G; Li AA; Dennis BB; Toll AE; Kim D; Bonham CA; Nair S; Ahmed A
    Clin Gastroenterol Hepatol; 2019 Jul; 17(8):1634-1636. PubMed ID: 30268562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization of increased risk for transmission of infectious disease donor organs in solid organ transplantation: Retrospective analysis of disease transmission and safety.
    Irwin L; Kotton CN; Elias N; Palafox J; Basler D; Shao SH; Lester W; Zhang X; Kimball B; Trencher C; Fishman JA
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28994164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C transmission from seropositive, nonviremic donors to non-hepatitis C liver transplant recipients.
    Bari K; Luckett K; Kaiser T; Diwan T; Cuffy M; Schoech MR; Safdar K; Blackard JT; Apewokin S; Paterno F; Sherman KE; Zucker SD; Anwar N; Shah SA
    Hepatology; 2018 May; 67(5):1673-1682. PubMed ID: 29205441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplantation of hepatitis C virus (HCV) antibody positive, nucleic acid test negative donor kidneys to HCV negative patients frequently results in seroconversion but not HCV viremia.
    de Vera ME; Volk ML; Ncube Z; Blais S; Robinson M; Allen N; Evans R; Weissman J; Baron P; Kore A; Bratton C; Garnett G; Hoang T; Wai P; Villicana R
    Am J Transplant; 2018 Oct; 18(10):2451-2456. PubMed ID: 30040178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are we underestimating the quality of aviremic hepatitis C-positive kidneys? Time to reconsider.
    Sibulesky L; Kling CE; Blosser C; Johnson CK; Limaye AP; Bakthavatsalam R; Leca N; Perkins JD
    Am J Transplant; 2018 Oct; 18(10):2465-2472. PubMed ID: 29451354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal transplantation from seropositive hepatitis C virus donors to seronegative recipients in Spain: a prospective study.
    Franco A; Moreso F; Merino E; Sancho A; Kanter J; Gimeno A; Balibrea N; Rodriguez M; Perez Contreras F
    Transpl Int; 2019 Jul; 32(7):710-716. PubMed ID: 30773693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of HCV-Positive Livers in HCV-Negative Recipients.
    Thuluvath PJ; Bruno DA; Alukal J; Satapathy SK; Thuluvath AJ; Zhang T
    Am J Gastroenterol; 2020 Jul; 115(7):1045-1054. PubMed ID: 32618655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with hepatitis C antibody seroconversion after transplantation of kidneys from hepatitis C infected donors to hepatitis C naïve recipients.
    Agbim U; Cseprekal O; Yazawa M; Talwar M; Balaraman V; Bhalla A; Podila PSB; Maliakkal B; Nair S; Eason JD; Molnar MZ
    Ren Fail; 2020 Nov; 42(1):767-775. PubMed ID: 32729359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.